Morgan Stanley Icad Inc Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Icad Inc stock. As of the latest transaction made, Morgan Stanley holds 57,600 shares of ICAD stock, worth $74,880. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,600
Previous 84,834
32.1%
Holding current value
$74,880
Previous $150,000
38.67%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ICAD
# of Institutions
56Shares Held
6.29MCall Options Held
18.2KPut Options Held
37.5K-
Portolan Capital Management, LLC Boston, MA1.21MShares$1.57 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.09MShares$1.41 Million0.0% of portfolio
-
First Eagle Investment Management, LLC702KShares$911,9820.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny491KShares$638,4450.0% of portfolio
-
Black Rock Inc. New York, NY353KShares$458,2780.0% of portfolio
About ICAD INC
- Ticker ICAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,333,900
- Market Cap $32.9M
- Description
- iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...